Technion researchers have successfully treated a cancerous tumor using a “nano-factory” — a synthetic cell that produces anti-cancer proteins within the tumor tissue. The research, which was published in Advanced Healthcare Materials, combines synthetic biology, to artificially produce proteins, and targeted drug delivery, to direct the synthetic cell to abnormal tissues. The synthetic cells are…
Novel Amyloid Structure Holds Promise for New Antibiotics
The highly pathogenic Staphylococcus aureus bacteria is one of the five most common causes of hospital-acquired infections. In the U.S. alone, approximately 500,000 patients at hospitals contract a staph infection. It is the bacteria responsible for MRSA, for which there is no vaccine. But all that could change, thanks to groundbreaking findings published in Science…